|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/10/14 Xenetic Biosciences, Inc. 10-Q 11/30/13 40:1.2M Timber Pharmas, Inc. |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report -- mainbody HTML 118K
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 15K
3: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 16K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
39: R1 Document and Entity Information HTML 39K
29: R2 Balance Sheets HTML 78K
26: R3 Balance Sheets (Parenthetical) HTML 33K
15: R4 Statements of Operations HTML 53K
28: R5 Statements of Cash Flows HTML 55K
20: R6 Organization and Summary of Significant Accounting HTML 31K
Policies
34: R7 Going Concern HTML 18K
21: R8 Fixed Assets HTML 26K
23: R9 Current Liabilities HTML 20K
16: R10 Long-Term Debt HTML 19K
22: R11 Related Party Transactions HTML 21K
33: R12 Stockholders’ Equity HTML 24K
31: R13 Subsequent Events HTML 18K
27: R14 Organization and Summary of Significant Accounting HTML 61K
Policies (Policies)
36: R15 Fixed Assets (Tables) HTML 23K
32: R16 Current Liabilities (Tables) HTML 19K
13: R17 Organization and Summary of Significant Accounting HTML 18K
Policies (Details Narrative)
18: R18 Going Concern (Details Narrative) HTML 20K
35: R19 FIXED ASSETS - Schedule of Fixed Assets (Details) HTML 26K
38: R20 Fixed Assets (Details Narrative) HTML 25K
40: R21 CURRENT LIABILITIES - Schedule of Current HTML 22K
Liabilities (Details)
37: R22 Long-Term Debt (Details Narrative) HTML 32K
30: R23 Related Party Transactions (Details Narrative) HTML 30K
17: R24 Stockholders Equity (Details Narrative) HTML 28K
25: XML IDEA XML File -- Filing Summary XML 49K
14: EXCEL IDEA Workbook of Financial Reports XLSX 44K
24: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 119K
7: EX-101.INS XBRL Instance -- gaif-20131130 XML 174K
9: EX-101.CAL XBRL Calculations -- gaif-20131130_cal XML 60K
10: EX-101.DEF XBRL Definitions -- gaif-20131130_def XML 68K
11: EX-101.LAB XBRL Labels -- gaif-20131130_lab XML 265K
12: EX-101.PRE XBRL Presentations -- gaif-20131130_pre XML 213K
8: EX-101.SCH XBRL Schema -- gaif-20131130 XSD 61K
19: ZIP XBRL Zipped Folder -- 0001504167-14-000015-xbrl Zip 34K
|
ROSS MILLER Secretary of State 206 North Carson Street Carson City, Nevada 89701-4299 (775) 684 5708 Website: secretaryofstate.biz |
|
| Certificate of Change Pursuant to NRS 78.209 | |
| USE BLACK INK ONLY – DO NOT HIGHLIGHT | ABOVE SPACE IS FOR OFFICE USE ONLY |
| Certificate of Change filed Pursuant to NRS 78.209 For Nevada Profit Corporations | |
| 1. Name of corporation: | |
| Xenetic Biosciences, Inc. | |
| 2. The board of directors have adopted a resolution pursuant to NRS 78.209 and have obtained any required approval of the stockholders. | |
| 3. The current number of authorized shares at the par value, if any, of each class or series, if any, of shares before the change: | |
300,000,000 shares of common stock, par value $0.001 10,000,000 shares of preferred stock, par value $0.001 | |
| 4. The number of authorized shares and the par value, if any, of each class or series, if any, of shares after the change: | |
300,000,000 shares of common stock, par value $0.01 10,000,000 shares of preferred stock, par value $0.001 | |
| 5. The number of shares of each affected class or series, if any, to be issued after the change in exchange for each issue share of the same class or series: | |
| 1 share will be issued for every 10 shares issued and outstanding | |
| 6. The provisions, if any, for the issuance of fractional shares, or for the payment of money or the issuance of scrip to stockholders otherwise entitled to a fraction of a share and the percentage of outstanding shares affected thereby: | |
| fractional shares will be rounded to the nearest whole number | |
| 7. Effective date of filing (optional): | |
| 8. Officer Signature: X /s/ Ari L. Nagler | |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/21/24 Xenetic Biosciences, Inc. 10-K 12/31/23 71:5.6M GlobalOne Filings Inc/FA 3/22/23 Xenetic Biosciences, Inc. 10-K 12/31/22 74:6.6M GlobalOne Filings Inc/FA 3/22/22 Xenetic Biosciences, Inc. 10-K 12/31/21 75:6M GlobalOne Filings Inc/FA 12/30/21 Xenetic Biosciences, Inc. S-8 12/30/21 3:87K GlobalOne Filings Inc/FA 10/20/21 Xenetic Biosciences, Inc. S-3/A 1:366K GlobalOne Filings Inc/FA 10/12/21 Xenetic Biosciences, Inc. S-3 5:1.3M GlobalOne Filings Inc/FA 8/13/21 Xenetic Biosciences, Inc. S-3 3:201K GlobalOne Filings Inc/FA 3/16/21 Xenetic Biosciences, Inc. 10-K 12/31/20 78:5.1M GlobalOne Filings Inc/FA |